Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Multiple Myeloma 1Metastatic Hormone Refractory Prostate Cancer 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia 1Blast Crisis 1

Interventions

Cyclophosphamide 80Peripheral Blood Stem Cell Transplantation 74fludarabine phosphate 73Busulfan 53Tacrolimus 50Cyclosporine 48Methotrexate 45Antilymphocyte Serum 45Mycophenolic Acid 43Filgrastim 39Radiotherapy 36Whole-Body Irradiation 35Methylprednisolone 28Melphalan 25Cord Blood Stem Cell Transplantation 24Cytarabine 21Etoposide 20sargramostim 14Thiotepa 13Flow Cytometry 13Imatinib Mesylate 12merphos 11Therapeutics 10Sirolimus 10Rituximab 10Dasatinib 9Psychiatric Rehabilitation 8Transplantation 7Polymerase Chain Reaction 7Carboplatin 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myeloid, Accelerated Phase × danusertib × Clear all
NCT00335868 2013-12-18

PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy

National Cancer Institute (NCI)

Phase 2 Unknown
16 enrolled
Other hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡